Doomed to die, one man chose a risky experiment that changed history
A Leap of Faith in Medicine
Doomed to die one man chose – In Boston, Tim Andrews faced a grim reality: his kidneys had failed, and doctors told him he had little time left. With no viable option for a human donor in sight, he was prepared to wait five years for a spot on the transplant list. But as his health deteriorated, Andrews realized that waiting might mean watching his life slip away. He could no longer walk, and his appetite had vanished. The choice was clear—he would take a chance on a groundbreaking procedure that could save him and, potentially, countless others.
“I’m gonna die anyway, so why wouldn’t I do something for all these people who are suffering?”
Tim Andrews, a retired grocery store manager from Concord, New Hampshire, made his decision with a mix of desperation and hope. He agreed to undergo a pioneering surgery involving a pig kidney, a bold move that placed him at the forefront of medical innovation. The operation was a gamble, but for Andrews, it was worth the risk.
Two years after the surgery, the gamble has paid off. Andrews, now 68, reports feeling healthier than he has in years. “I’m laughing again,” he said, recalling his self-proclaimed title of “pig man.” The procedure, once considered a futuristic fantasy, has become a tangible reality for him—and a symbol of the transformative power of modern medicine.
The Evolution of Transplantation
The field of organ transplantation has come a long way since its earliest days. In 1954, the first successful human-to-human kidney transplant took place just a few miles from where Andrews received his pig kidney. That milestone marked the beginning of a journey that has seen both remarkable progress and persistent challenges. Today, the science of transplantation is more advanced than ever, yet the demand for organs far outpaces the supply.
More than 100,000 Americans are currently on transplant waiting lists, with the majority awaiting a kidney. The average wait time can be years, and many patients fear they won’t survive long enough to receive one. For kidneys and some liver transplants, live donations offer a lifeline—someone can give a kidney or a portion of their liver and still live a normal life. However, not everyone has a living match, and the process is not always straightforward.
Andrews, like many others, relied on a deceased donor. Only about three out of every 1,000 people die in a way that allows their organs to be donated, such as a heart or lungs. This scarcity has driven researchers to explore alternative solutions, leading to the development of xenotransplantation—the use of animal organs in humans.
Pig Organs and the Promise of Xenotransplantation
Pig kidneys, in particular, have become a focal point of this medical revolution. Their size and function closely mirror human organs, making them ideal candidates for transplant. But the process of using them was once thought impossible. Scientists had to overcome the body’s natural rejection mechanisms, which treat foreign tissues as threats. This breakthrough came through gene editing, allowing pigs to be bred with organs that are more compatible with humans.
“We’re expanding the pool by using what we used to call ‘marginal’ organs,” explained Dr. Nahel Elias, surgical director for kidney transplantation at Massachusetts General Hospital. “But at the end of the day, dead people are dead for a reason. Young, healthy people don’t just drop dead.” Elias highlighted the growing reliance on organs from older or sicker donors, a shift made possible by advances in medical science.
The idea of using animal organs to save human lives has long been debated. Some view xenotransplantation as ethical dilemmas, questioning the use of pigs in life-or-death situations. However, Americans eat over 130 million pigs annually, underscoring the familiarity with animal-derived products. Pig and cow tissues have already been used in medical settings for decades, suggesting a broader acceptance of their potential in more complex procedures.
Andrews’ case is part of a small but growing group of recipients. As of now, only 10 Americans have undergone pig-to-human kidney transplants, with six still alive. His 271-day survival record is a testament to the success of this experimental approach. Doctors aim to extend these survival rates into years, with clinical trials in 2026 testing the long-term viability of pig organs in more patients.
Dr. Shimul Shah, clinical director and chief of transplant surgery at Mass General Brigham Transplant, called the current era “the golden age” of transplantation. The combination of improved organ availability and promising xenotransplantation research is reshaping the future of medicine. For Andrews, this new age is more than a scientific achievement—it’s a personal triumph.
His story reflects the broader American journey in transplantation, one defined by audacious ideas, calculated risks, and a commitment to innovation. From the first kidney transplant to the pig kidney breakthrough, the path has been marked by perseverance and the pursuit of solutions to a problem that has plagued healthcare for decades. As the technology continues to evolve, the hope is that more patients will have the chance to live longer, healthier lives—just like Andrews.
The road ahead remains uncertain, but the progress made so far is undeniable. With continued research and the growing use of pig organs, the dream of matching every patient with an organ may soon become a reality. For now, Andrews stands as a living reminder of what can be achieved when science dares to challenge the limits of the human body.
